• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).

作者信息

Nieman Koen, Serruys Patrick W, Onuma Yoshinobu, van Geuns Robert-Jan, Garcia-Garcia Hector M, de Bruyne Bernard, Thuesen Leif, Smits Pieter C, Koolen Jacques J, McClean Dougal, Chevalier Bernard, Meredith Ian, Ormiston John

机构信息

Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

J Am Coll Cardiol. 2013 Nov 5;62(19):1813-4. doi: 10.1016/j.jacc.2013.07.030. Epub 2013 Aug 7.

DOI:10.1016/j.jacc.2013.07.030
PMID:23933536
Abstract
摘要

相似文献

1
Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).多层螺旋计算机断层扫描血管造影术用于无创评估一种新型可透射线生物可吸收血管支架装置的18个月性能：ABSORB试验（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估）
J Am Coll Cardiol. 2013 Nov 5;62(19):1813-4. doi: 10.1016/j.jacc.2013.07.030. Epub 2013 Aug 7.
2
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果：ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
3
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.ABSORB II 随机对照临床试验：比较 Absorb 依维莫司洗脱生物可吸收血管支架系统与 XIENCE 依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变所致缺血性心脏病患者的安全性、疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2012 Nov;164(5):654-63. doi: 10.1016/j.ahj.2012.08.010.
4
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果：ABSORB 队列 B 试验的光学相干断层成像评估（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
5
Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.EVOLVE 试验的主要终点结果：一种新型可生物吸收聚合物涂层、依维莫司洗脱冠状动脉支架的随机评估。
J Am Coll Cardiol. 2012 Apr 10;59(15):1362-70. doi: 10.1016/j.jacc.2011.12.016. Epub 2012 Feb 15.
6
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中，435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局：与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。
JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.
7
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.依维莫司和紫杉醇洗脱支架置入术后 3 年的临床随访：来自 SPIRIT II（依维莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）和 SPIRIT III（依维莫司洗脱冠状动脉支架系统[EECSS]治疗初发冠状动脉病变患者的临床评估）随机试验的汇总分析。
JACC Cardiovasc Interv. 2010 Dec;3(12):1220-8. doi: 10.1016/j.jcin.2010.07.017.
8
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.多部位、多血管病变患者中应用依维莫司洗脱支架和紫杉醇洗脱支架的对比：SPIRIT III 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统（EECSS）的 XIENCE V 血管内介入器械的临床评估）和 SPIRIT IV 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统的 XIENCE V 血管内介入器械的临床评估）随机临床试验。
JACC Cardiovasc Interv. 2010 Dec;3(12):1229-39. doi: 10.1016/j.jcin.2010.09.014.
9
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).3 年临床随访结果：新一代西罗莫司洗脱冠状动脉支架系统（XIENCE V）治疗初发冠状动脉病变的 SPIRIT II 临床试验（新一代西罗莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）。
JACC Cardiovasc Interv. 2009 Dec;2(12):1190-8. doi: 10.1016/j.jcin.2009.10.002.
10
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.XIENCE V 依维莫司洗脱冠状动脉支架系统治疗多支血管病变患者的临床和血管造影研究。EXECUTIVE 试验的设计和原理。
J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69.

引用本文的文献

1
Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group.基于人工智能的冠状动脉CT血管造影评估在动脉粥样硬化个体化医疗中的应用：QCI研究组共识声明
Nat Rev Cardiol. 2025 Aug 1. doi: 10.1038/s41569-025-01191-6.
2
The Bioresorbable Stent in Perspective-How Much of an Advance is It?可生物吸收支架展望——它的进步有多大？
Interv Cardiol. 2014 Mar;9(1):23-25. doi: 10.15420/icr.2011.9.1.23.
3
Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography.
冠状动脉计算机断层扫描血管造影术用于生物可吸收支架管腔研究的准确性：与光学相干断层扫描的比较。
Int J Cardiovasc Imaging. 2017 Mar;33(3):431-439. doi: 10.1007/s10554-016-1018-6. Epub 2016 Nov 28.
4
Costs and clinical outcomes for non-invasive versus invasive diagnostic approaches to patients with suspected in-stent restenosis.疑似支架内再狭窄患者采用非侵入性与侵入性诊断方法的成本及临床结果
Int J Cardiovasc Imaging. 2016 Feb;32(2):309-315. doi: 10.1007/s10554-015-0758-z. Epub 2015 Sep 3.
5
Noninvasive Measurement of Coronary Fractional Flow Reserve: An Under-exploiting Newland.冠状动脉血流储备分数的无创测量：一个未被充分利用的新领域。
Chin Med J (Engl). 2015 Jun 20;128(12):1695-9. doi: 10.4103/0366-6999.158383.
6
Bioresorbable scaffolds for percutaneous coronary interventions.用于经皮冠状动脉介入治疗的生物可吸收支架
Glob Cardiol Sci Pract. 2014 Dec 31;2014(4):409-27. doi: 10.5339/gcsp.2014.55. eCollection 2014.
7
Next generation coronary CT angiography: in vitro evaluation of 27 coronary stents.新一代冠状动脉CT血管造影：27个冠状动脉支架的体外评估
Eur Radiol. 2014 Nov;24(11):2953-61. doi: 10.1007/s00330-014-3323-6. Epub 2014 Jul 21.
8
The effects of novel, bioresorbable scaffolds on coronary vascular pathophysiology.新型生物可吸收支架对冠状动脉病理生理学的影响。
J Cardiovasc Transl Res. 2014 Jun;7(4):413-25. doi: 10.1007/s12265-014-9571-7. Epub 2014 May 7.